Response to "Standing Guard"
The article “Standing Guard” was published on the PDA Letter website Sept. 26. This response addresses what we consider misleading conclusions within the article. As manufacturers of recombinant Factor C (rFC) endotoxin detection assays—known as the bioMérieux ENDONEXT™ family of products, we are committed to providing an accurate portrayal of the emerging limulus amebocyte lysate (LAL) replacement reagent rFC.